Arrhythmia Disorders News

Boston Scientific announced it received FDA approval to expand the indication for its pacing leads to include conduction system pacing of the left bundle branch area when connected to a single- or dual-chamber pacemaker.

Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.

Biotronik announced it received FDA labeling approval of its stylet-driven lead and delivery catheter system for left bundle branch area pacing.

Catching up on sleep over the weekend was associated with lower likelihood of having heart disease compared with individuals who slept less than they would during the week, a speaker reported.

Patients with atrial fibrillation needing stroke prevention assigned to abelacimab had very low rates of bleeding during invasive procedures, according to new data from the AZALEA-TIMI 71 trial.

In patients with atrial fibrillation and heart failure with reduced ejection fraction, cryoballoon ablation was noninferior to radiofrequency ablation, according to the results of the CRABL-HF trial.

Mass ECG screening for atrial fibrillation in older adults did not reduce the incidence of stroke or stroke hospitalization, according to the results of two trials presented at the European Society of Cardiology Congress.

Nearly one in 20 adults in the U.S. are estimated to have atrial fibrillation, many more than previous studies had indicated, according to new data out of the University of California, San Francisco.

Among people who had ever smoked, those who quit had reduced risk for incident atrial fibrillation compared with those who had not, according to new data from the UK Biobank.

B-Secur announced the FDA clearance and launch of its ECG algorithms and analytics designed to enhance signal clarity by reducing noise, improving ECG interpretability.